Modeling of chronic radiation-induced cystitis in mice

Bernadette M.M. Zwaans, Sarah Krueger, Sarah N. Bartolone, Michael B. Chancellor, Brian Marples, Laura E. Lamb

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose Radiation cystitis (RC), a severe inflammatory bladder condition, develops as a side effect of pelvic radiation therapy in cancer patients. There are currently no effective therapies to treat RC, in part from the lack of preclinical model systems. In this study, we developed a mouse model for RC and used a Small Animal Radiation Research Platform to simulate the targeted delivery of radiation as used with human patients. Methods and materials To induce RC, C3H mice received a single radiation dose of 20 Gy delivered through 2 beams. Mice were subjected to weekly micturition measurements to assess changes in urinary frequency. At the end of the study, bladder tissues were processed for histology. Results Radiation was well-tolerated; no change in weight was observed in the weeks after treatment, and there was no hair loss at the irradiation sites. Starting at 17 weeks after treatment, micturition frequency was significantly higher in irradiated mice versus control animals. Pathological changes include fibrosis, inflammation, urothelial thinning, and necrosis. At a site of severe insult, we observed telangiectasia, absence of uroplakin-3 and E-cadherin relocalization. Conclusions We developed an RC model that mimics the human pathology and functional changes. Furthermore, radiation exposure attenuates the urothelial integrity long-term, allowing for potential continuous irritability of the bladder wall from exposure to urine. Future studies will focus on the underlying molecular changes associated with this condition and investigate novel treatment strategies.

Original languageEnglish (US)
Pages (from-to)333-343
Number of pages11
JournalAdvances in Radiation Oncology
Volume1
Issue number4
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

Cystitis
Radiation
Urinary Bladder
Urination
Uroplakins
Telangiectasis
Inbred C3H Mouse
Alopecia
Cadherins
Therapeutics
Histology
Fibrosis
Necrosis
Radiotherapy
Urine
Pathology
Inflammation
Weights and Measures

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Zwaans, B. M. M., Krueger, S., Bartolone, S. N., Chancellor, M. B., Marples, B., & Lamb, L. E. (2016). Modeling of chronic radiation-induced cystitis in mice. Advances in Radiation Oncology, 1(4), 333-343. https://doi.org/10.1016/j.adro.2016.07.004

Modeling of chronic radiation-induced cystitis in mice. / Zwaans, Bernadette M.M.; Krueger, Sarah; Bartolone, Sarah N.; Chancellor, Michael B.; Marples, Brian; Lamb, Laura E.

In: Advances in Radiation Oncology, Vol. 1, No. 4, 01.10.2016, p. 333-343.

Research output: Contribution to journalArticle

Zwaans, BMM, Krueger, S, Bartolone, SN, Chancellor, MB, Marples, B & Lamb, LE 2016, 'Modeling of chronic radiation-induced cystitis in mice', Advances in Radiation Oncology, vol. 1, no. 4, pp. 333-343. https://doi.org/10.1016/j.adro.2016.07.004
Zwaans, Bernadette M.M. ; Krueger, Sarah ; Bartolone, Sarah N. ; Chancellor, Michael B. ; Marples, Brian ; Lamb, Laura E. / Modeling of chronic radiation-induced cystitis in mice. In: Advances in Radiation Oncology. 2016 ; Vol. 1, No. 4. pp. 333-343.
@article{0ec22a503c3441a8aef5bdc9bf64d068,
title = "Modeling of chronic radiation-induced cystitis in mice",
abstract = "Purpose Radiation cystitis (RC), a severe inflammatory bladder condition, develops as a side effect of pelvic radiation therapy in cancer patients. There are currently no effective therapies to treat RC, in part from the lack of preclinical model systems. In this study, we developed a mouse model for RC and used a Small Animal Radiation Research Platform to simulate the targeted delivery of radiation as used with human patients. Methods and materials To induce RC, C3H mice received a single radiation dose of 20 Gy delivered through 2 beams. Mice were subjected to weekly micturition measurements to assess changes in urinary frequency. At the end of the study, bladder tissues were processed for histology. Results Radiation was well-tolerated; no change in weight was observed in the weeks after treatment, and there was no hair loss at the irradiation sites. Starting at 17 weeks after treatment, micturition frequency was significantly higher in irradiated mice versus control animals. Pathological changes include fibrosis, inflammation, urothelial thinning, and necrosis. At a site of severe insult, we observed telangiectasia, absence of uroplakin-3 and E-cadherin relocalization. Conclusions We developed an RC model that mimics the human pathology and functional changes. Furthermore, radiation exposure attenuates the urothelial integrity long-term, allowing for potential continuous irritability of the bladder wall from exposure to urine. Future studies will focus on the underlying molecular changes associated with this condition and investigate novel treatment strategies.",
author = "Zwaans, {Bernadette M.M.} and Sarah Krueger and Bartolone, {Sarah N.} and Chancellor, {Michael B.} and Brian Marples and Lamb, {Laura E.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.adro.2016.07.004",
language = "English (US)",
volume = "1",
pages = "333--343",
journal = "Advances in Radiation Oncology",
issn = "2452-1094",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Modeling of chronic radiation-induced cystitis in mice

AU - Zwaans, Bernadette M.M.

AU - Krueger, Sarah

AU - Bartolone, Sarah N.

AU - Chancellor, Michael B.

AU - Marples, Brian

AU - Lamb, Laura E.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Purpose Radiation cystitis (RC), a severe inflammatory bladder condition, develops as a side effect of pelvic radiation therapy in cancer patients. There are currently no effective therapies to treat RC, in part from the lack of preclinical model systems. In this study, we developed a mouse model for RC and used a Small Animal Radiation Research Platform to simulate the targeted delivery of radiation as used with human patients. Methods and materials To induce RC, C3H mice received a single radiation dose of 20 Gy delivered through 2 beams. Mice were subjected to weekly micturition measurements to assess changes in urinary frequency. At the end of the study, bladder tissues were processed for histology. Results Radiation was well-tolerated; no change in weight was observed in the weeks after treatment, and there was no hair loss at the irradiation sites. Starting at 17 weeks after treatment, micturition frequency was significantly higher in irradiated mice versus control animals. Pathological changes include fibrosis, inflammation, urothelial thinning, and necrosis. At a site of severe insult, we observed telangiectasia, absence of uroplakin-3 and E-cadherin relocalization. Conclusions We developed an RC model that mimics the human pathology and functional changes. Furthermore, radiation exposure attenuates the urothelial integrity long-term, allowing for potential continuous irritability of the bladder wall from exposure to urine. Future studies will focus on the underlying molecular changes associated with this condition and investigate novel treatment strategies.

AB - Purpose Radiation cystitis (RC), a severe inflammatory bladder condition, develops as a side effect of pelvic radiation therapy in cancer patients. There are currently no effective therapies to treat RC, in part from the lack of preclinical model systems. In this study, we developed a mouse model for RC and used a Small Animal Radiation Research Platform to simulate the targeted delivery of radiation as used with human patients. Methods and materials To induce RC, C3H mice received a single radiation dose of 20 Gy delivered through 2 beams. Mice were subjected to weekly micturition measurements to assess changes in urinary frequency. At the end of the study, bladder tissues were processed for histology. Results Radiation was well-tolerated; no change in weight was observed in the weeks after treatment, and there was no hair loss at the irradiation sites. Starting at 17 weeks after treatment, micturition frequency was significantly higher in irradiated mice versus control animals. Pathological changes include fibrosis, inflammation, urothelial thinning, and necrosis. At a site of severe insult, we observed telangiectasia, absence of uroplakin-3 and E-cadherin relocalization. Conclusions We developed an RC model that mimics the human pathology and functional changes. Furthermore, radiation exposure attenuates the urothelial integrity long-term, allowing for potential continuous irritability of the bladder wall from exposure to urine. Future studies will focus on the underlying molecular changes associated with this condition and investigate novel treatment strategies.

UR - http://www.scopus.com/inward/record.url?scp=85007399502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007399502&partnerID=8YFLogxK

U2 - 10.1016/j.adro.2016.07.004

DO - 10.1016/j.adro.2016.07.004

M3 - Article

VL - 1

SP - 333

EP - 343

JO - Advances in Radiation Oncology

JF - Advances in Radiation Oncology

SN - 2452-1094

IS - 4

ER -